Inventor · disambiguated record
Adrian Wiestner
Also filed as: WIESTNER ADRIAN · WIESTNER ADRIAN U
7 granted patents·2 pending applications·29 citations·filing 2002–2024
79Inventor score
Top patents by PatentIndex Score
9 records- 0186US7329502B2ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)US HEALTH·Filed 2002·Granted Feb 12, 2008·22 cites·14 claims
- 0280US10035848B2Antibody targeting cell surface deposited complement protein C3d and use thereofUS HEALTH·Filed 2015·Granted Jul 31, 2018·4 cites·25 claims
- 0380US7981610B2ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)US HEALTH·Filed 2007·Granted Jul 19, 2011·2 cites·10 claims
- 0473US2025296989A1ANTIBODIES TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOFUS HEALTH·Filed 2024·Application pending·0 cites
- 0559US8748114B2ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)STAUDT LOUIS M·Filed 2011·Granted Jun 10, 2014·0 cites·20 claims
- 0655US11384139B2Antibody targeting cell surface deposited complement protein C3d and use thereofUS HEALTH·Filed 2018·Granted Jul 12, 2022·0 cites·20 claims
- 0752US8518968B2Hydrazone and diacyl hydrazine compounds and methods of useWIESTNER ADRIAN·Filed 2010·Granted Aug 27, 2013·1 cites·20 claims
- 0852US2023029635A1ANTIBODIES TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOFUS HEALTH·Filed 2020·Application pending·0 cites
- 0934US8637560B2Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatmentTRENKLE WILLIAM·Filed 2008·Granted Jan 28, 2014·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Adrian Wiestner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →